Hesperetin suppresses LPS/high glucose-induced inflammatory responses via TLR/MyD88/NF-κB signaling pathways in THP-1 cells
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES Unregulated inflammatory responses caused by hyperglycemia may induce diabetes complications. Hesperetin, a bioflavonoid, is a glycoside in citrus fruits and is known to have antioxidant and anticarcinogenic properties. However, the effect of inflammation on the diabetic environment has not been reported to date. In this study, we investigated the effect of hesperetin on proinflammatory cytokine secretion and its underlying mechanistic regulation in THP-1 macrophages with co-treatment LPS and hyperglycemic conditions. MATERIALS/METHODS THP-1 cells differentiated by PMA (1 μM) were cultured for 48 h in the presence or absence of hesperetin under normoglycemic (5.5 mM/L glucose) or hyperglycemic (25 mM/L glucose) conditions and then treated with LPS (100 ng/mL) for 6 h before harvesting. Inflammation-related proteins and mRNA levels were evaluated by enzyme-linked immunosorbent assay, western blot, and quantitative polymerase chain reaction analyses. RESULTS Hesperetin (0–100 μM, 48 h) treatment did not affect cell viability. The tumor necrosis factor-α and interleukin-6 levels increased in cells co-treated with LPS under hyperglycemic conditions compared to normoglycemic conditions, and these increases were decreased by hesperetin treatment. The TLR2/4 and MyD88 activity levels increased in cells co-treated with LPS under hyperglycemic conditions compared to normoglycemic conditions; however, hesperetin treatment inhibited the TLR2/4 and MyD88 activity increases. In addition, nuclear factor-κB (NF-κB) and Acetyl-NF-κB levels increased in response to treatment with LPS under hyperglycemic conditions compared to normoglycemic conditions, but those levels were decreased when treated with hesperetin. SIRT3 and SIRT6 expressions were increased by hesperetin treatment. CONCLUSIONS Our results suggest that hesperetin may be a potential agent for suppressing inflammation in diabetes.
Abstract
BACKGROUND/OBJECTIVES Unregulated inflammatory responses caused by hyperglycemia may induce diabetes complications. Hesperetin, a bioflavonoid, is a glycoside in citrus fruits and is known to have antioxidant and anticarcinogenic properties. However, the effect of inflammation on the diabetic environment has not been reported to date. In this study, we investigated the effect of hesperetin on proinflammatory cytokine secretion and its underlying mechanistic regulation in THP-1 macrophages with co-treatment LPS and hyperglycemic conditions. MATERIALS/METHODS THP-1 cells differentiated by PMA (1 μM) were cultured for 48 h in the presence or absence of hesperetin under normoglycemic (5.5 mM/L glucose) or hyperglycemic (25 mM/L glucose) conditions and then treated with LPS (100 ng/mL) for 6 h before harvesting. Inflammation-related proteins and mRNA levels were evaluated by enzyme-linked immunosorbent assay, western blot, and quantitative polymerase chain reaction analyses. RESULTS Hesperetin (0–100 μM, 48 h) treatment did not affect cell viability. The tumor necrosis factor-α and interleukin-6 levels increased in cells co-treated with LPS under hyperglycemic conditions compared to normoglycemic conditions, and these increases were decreased by hesperetin treatment. The TLR2/4 and MyD88 activity levels increased in cells co-treated with LPS under hyperglycemic conditions compared to normoglycemic conditions; however, hesperetin treatment inhibited the TLR2/4 and MyD88 activity increases. In addition, nuclear factor-κB (NF-κB) and Acetyl-NF-κB levels increased in response to treatment with LPS under hyperglycemic conditions compared to normoglycemic conditions, but those levels were decreased when treated with hesperetin. SIRT3 and SIRT6 expressions were increased by hesperetin treatment. CONCLUSIONS Our results suggest that hesperetin may be a potential agent for suppressing inflammation in diabetes.
참고문헌 (49)
- Capes SE, "Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes : a systematic overview", Lancet, 355, pp.773~778 (2000)
- Urakami T, "Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area", Diabetes Care, 28, pp.1876~1881 (2005)
- Saeedi P, "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045 : results from the International Diabetes Federation Diabetes Atlas, 9th edition", Diabetes Res Clin Pract, 157, pp.107843~ (2019)
- Lumeng CN, "Inflammatory links between obesity and metabolic disease", J Clin Invest, 121, pp.2111~2117 (2011)
- Calles-Escandon J, "Diabetes and endothelial dysfunction : a clinical perspective", Endocr Rev, 22, pp.36~52 (2001)
- Shanmugam N, "Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products", J Biol Chem, 278, pp.34834~34844 (2003)
- de Winther MP, "Nuclear factor kappaB signaling in atherogenesis", Arterioscler Thromb Vasc Biol, 25, pp.904~914 (2005)
- Arkan MC, "IKK-beta links inflammation to obesity-induced insulin resistance", Nat Med, 11, pp.191~198 (2005)
- 양선미, "제2형 당뇨병환자에서 미세혈관 합병증과 염증 인자들의 연관성", Diabetes and Metabolism Journal, 31(6), pp.472~479 (2007), 대한당뇨병학회
- Dasu MR, "Toll-like receptors and diabetes : a therapeutic perspective", Clin Sci(Lond), 122, pp.203~214 (2012)
- Rhee SH, "Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase", J Biol Chem, 275, pp.34035~34040 (2000)
- Liang H, "Effect of lipopolysaccharide on inflammation and insulin action in human muscle", PLoS One, 8, pp.e63983~ (2013)
- 박범석, "Recognition of lipopolysaccharide pattern by TLR4complexes", Experimental and Molecular Medicine, 45(12), pp.1~9 (2013), 생화학분자생물학회
- Kany S, "Cytokines in inflammatory disease", Int J Mol Sci, 20, pp.20~ (2019)
- Haigis MC, "Mammalian sirtuins : biological insights and disease relevance", Annu Rev Pathol, 5, pp.253~295 (2010)
- Bosch-Presegué L, "The dual role of sirtuins in cancer", Genes Cancer, 2, pp.648~662 (2011)
- Ma Y, "NAD+ metabolism and NAD(+)-dependent enzymes : promising therapeutic targets for neurological diseases", Curr Drug Targets, 13, pp.222~229 (2012)
- Roth M, "Sorting out functions of sirtuins in cancer", Oncogene, 33, pp.1609~1620 (2014)
- Frye RA, "Characterization of five human cDNAs with homology to the yeast SIR2 gene : Sir2-like proteins(sirtuins)metabolize NAD and may have protein ADP-ribosyltransferase activity", Biochem Biophys Res Commun, 260, pp.273~279 (1999)
- Michishita E, "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins", Mol Biol Cell, 16, pp.4623~4635 (2005)
- Wang CH, "Roles of mitochondrial sirtuins in mitochondrial function, redox homeostasis, insulin resistance and type 2 diabetes", Int J Mol Sci, 21, pp.5266~ (2020)
- Kawahara TL, "SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span", Cell, 136, pp.62~74 (2009)
- Parhiz H, "Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin : an updated review of their molecular mechanisms and experimental models", Phytother Res, 29, pp.323~331 (2015)
- Aranganathan S, "Efficacy of the potential chemopreventive agent, hesperetin(citrus flavanone), on 1, 2-dimethylhydrazine induced colon carcinogenesis", Food Chem Toxicol, 47, pp.2594~2600 (2009)
- Morin B, "The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells", J Nutr, 138, pp.1274~1281 (2008)
- Kumar B, "Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats", Microvasc Res, 87, pp.65~74 (2013)
- Jialal I, "The role of toll-like receptors in diabetes-induced inflammation : implications for vascular complications", Curr Diab Rep, 12, pp.172~179 (2012)
- Amaral S, "Diabetes and the impairment of reproductive function : possible role of mitochondria and reactive oxygen species", Curr Diabetes Rev, 4, pp.46~54 (2008)
- Nishikawa T, "Investigation of a novel mechanism of diabetic complications : impacts of mitochondrial reactive oxygen species", Rinsho Byori, 56, pp.712~719 (2008)
- Jain SK, "Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes", Diabetes Care, 26, pp.2139~2143 (2003)
- Jain SK, "Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency", Diabetes, 51, pp.2287~2293 (2002)
- Kern PA, "Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance", Am J Physiol Endocrinol Metab., 280, pp.E745~E751 (2001)
- Yun JM, "Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin", J Nutr Biochem, 22, pp.450~458 (2011)
- Matulewicz N, "Insulin resistance and chronic inflammation", Postepy Hig Med Dosw, 70, pp.1245~1258 (2016)
- Wu H, "Metabolic inflammation and insulin resistance in obesity", Circ Res, 126, pp.1549~1564 (2020)
- Hossain M, "Association of serum TNF-α and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population", Int J Diabetes Mellit, 2, pp.165~168 (2010)
- Schmidt MI, "Markers of inflammation and prediction of diabetes mellitus in adults(Atherosclerosis Risk in Communities study) : a cohort study", Lancet, 353, pp.1649~1652 (1999)
- Xie C, "Blueberries reduce pro-inflammatory cytokine TNF-α and IL-6 production in mouse macrophages by inhibiting NF-κB activation and the MAPK pathway", Mol Nutr Food Res, 55, pp.1587~1591 (2011)
- Guha M, "Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and-independent pathways", J Biol Chem, 275, pp.17728~17739 (2000)
- Choi RY, "Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet", Chem Biol Interact, 260, pp.13~21 (2016)
- 이희재, "피세아테놀과 레스베라트롤의 혈당조절 및 TLR4-NF-κB 경로 조절 작용", 한국식품영양과학회지, 46(2), pp.267~272 (2017), 한국식품영양과학회
- Youn HS, "Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol : molecular targets are TBK1 and RIP1 in TRIF complex", J Immunol, 175, pp.3339~3346 (2005)
- Ghanim H, "Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression", Am J Clin Nutr, 91, pp.940~949 (2010)
- Hua KF, "High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase C-α", δ and NF-κB, 2012, pp.61, 1107~1116
- Yang F, "Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model", J Nutr, 128, pp.2334~2340 (1998)
- Tsai SH, "Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol", Br J Pharmacol, 126, pp.673~680 (1999)
- Chan MM, "Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway", Biochem Pharmacol, 60, pp.1539~1548 (2000)
- Huynh FK, "Targeting sirtuins for the treatment of diabetes", Diabetes Manag(Lond), 3, pp.245~257 (2013)
- Elliott P, "Resveratrol", SRT-501, 2009, pp.34, 291~295